474 related articles for article (PubMed ID: 19629403)
21. Environmental magnesium deficiency as a cardiovascular risk factor.
Rylander R
J Cardiovasc Risk; 1996 Feb; 3(1):4-10. PubMed ID: 8783025
[TBL] [Abstract][Full Text] [Related]
22. Hypomagnesemia in patients with type 2 diabetes.
Pham PC; Pham PM; Pham SV; Miller JM; Pham PT
Clin J Am Soc Nephrol; 2007 Mar; 2(2):366-73. PubMed ID: 17699436
[TBL] [Abstract][Full Text] [Related]
23. Magnesium deficiency and diabetes mellitus.
Sheehan JP
Magnes Trace Elem; 1991-1992; 10(2-4):215-9. PubMed ID: 1844554
[TBL] [Abstract][Full Text] [Related]
24. The role of magnesium in type 2 diabetes: a brief based-clinical review.
Rodríguez-Morán M; Simental Mendía LE; Zambrano Galván G; Guerrero-Romero F
Magnes Res; 2011 Dec; 24(4):156-62. PubMed ID: 22198525
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of magnesium in health and disease.
Ahsan SK
J Indian Med Assoc; 1997 Sep; 95(9):507-10. PubMed ID: 9529585
[TBL] [Abstract][Full Text] [Related]
26. Magnesium status and association with diabetes in the Taiwanese elderly.
Wang JL; Shaw NS; Yeh HY; Kao MD
Asia Pac J Clin Nutr; 2005; 14(3):263-9. PubMed ID: 16169838
[TBL] [Abstract][Full Text] [Related]
27. [Abnormalities of magnesium (Mg) metabolism and therapeutic significance of Mg administration in patients with metabolic syndrome, type 2 diabetes, heart failure and chronic hemodialysis].
Kikuchi K; Tanaka H; Gima M; Kashiwagi Y; Shida H; Kawamura Y; Hasebe N
Clin Calcium; 2012 Aug; 22(8):1217-26. PubMed ID: 22846358
[TBL] [Abstract][Full Text] [Related]
28. Magnesium in Prevention and Therapy.
Gröber U; Schmidt J; Kisters K
Nutrients; 2015 Sep; 7(9):8199-226. PubMed ID: 26404370
[TBL] [Abstract][Full Text] [Related]
29. Disorders of magnesium metabolism.
Nadler JL; Rude RK
Endocrinol Metab Clin North Am; 1995 Sep; 24(3):623-41. PubMed ID: 8575413
[TBL] [Abstract][Full Text] [Related]
30. Magnesium deficiency in critical illness.
Tong GM; Rude RK
J Intensive Care Med; 2005; 20(1):3-17. PubMed ID: 15665255
[TBL] [Abstract][Full Text] [Related]
31. Understanding type 2 diabetes mellitus and associated cardiovascular disease: linked by insulin resistance.
Tennyson GE
Am J Manag Care; 2002 Oct; 8(16 Suppl):S450-9. PubMed ID: 12408408
[TBL] [Abstract][Full Text] [Related]
32. The paradox of the contrasting roles of chronic magnesium deficiency in metabolic disorders and field cancerization.
Rubin H
Magnes Res; 2014; 27(3):94-102. PubMed ID: 25560238
[TBL] [Abstract][Full Text] [Related]
33. Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study.
Guerrero-Romero F; Rascón-Pacheco RA; Rodríguez-Morán M; de la Peña JE; Wacher N
Eur J Clin Invest; 2008 Jun; 38(6):389-96. PubMed ID: 18489400
[TBL] [Abstract][Full Text] [Related]
34. Role of magnesium in cardiovascular diseases.
Kolte D; Vijayaraghavan K; Khera S; Sica DA; Frishman WH
Cardiol Rev; 2014; 22(4):182-92. PubMed ID: 24896250
[TBL] [Abstract][Full Text] [Related]
35. Role of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes.
Bo S; Pisu E
Curr Opin Lipidol; 2008 Feb; 19(1):50-6. PubMed ID: 18196987
[TBL] [Abstract][Full Text] [Related]
36. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. I. Clinical aspects.
Altura BM; Altura BT
Magnesium; 1985; 4(5-6):226-44. PubMed ID: 3914580
[TBL] [Abstract][Full Text] [Related]
37. The multifaceted and widespread pathology of magnesium deficiency.
Johnson S
Med Hypotheses; 2001 Feb; 56(2):163-70. PubMed ID: 11425281
[TBL] [Abstract][Full Text] [Related]
38. Correlations suggest low magnesium may lead to higher rates of type 2 diabetes in Indigenous Australians.
Longstreet DA; Heath DL; Panaretto KS; Vink R
Rural Remote Health; 2007; 7(4):843. PubMed ID: 17937505
[TBL] [Abstract][Full Text] [Related]
39. Magnesium role in cardiovascular diseases.
Hordyjewska A; Pasternak K
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):108-13. PubMed ID: 16146060
[TBL] [Abstract][Full Text] [Related]
40. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
